OCGN FY 2023 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena

OCGNOcugen, Inc.

$578M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$6M+142.6% YoY

Gross Profit

$5M88.3% margin

Operating Income

-$66M-1085.7% margin

Net Income

-$63M-1045.0% margin

EPS (Diluted)

$-0.26

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$73M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$65M

Total Liabilities

$24M

Stockholders' Equity

$41M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$2M	+142.6%
Gross Profit	$5M	$2M	+114.3%
Operating Income	-$66M	-$89M	+26.4%
Net Income	-$63M	-$87M	+27.3%